Cancer Gene Therapy Industry Analysis

1
Cancer Gene Therapy Market Analysis
Published Date March 2014 No. of Pages 300
Price Single User US 1800 Price Corporate
User US 3600
2
New Market Research Report on Cancer Gene
Therapy Market Analysis added to
ReportsnReports.com
Order report Cancer Gene Therapy Market
Analysis by calling ReportsnReports.com at 1
888 391 5441 OR send an email on
sales_at_reportsandreports.com with Cancer Gene
Therapy Market Analysis in subject line and your
contact details. The gene therapy
market has undergone series of transformation
from the initial days of research to current
clinical development of drugs for treatment of
multiple diseases. The initial studies of gene
therapy were conducted mostly on monogenetic
diseases, but the focus of the researchers
rapidly shifted towards the cancer. The
increasing popularity of cancer therapeutics as a
major interest for gene therapy applications led
to it accounting for a dominant share of more
than 60 in the overall number of clinical
studies. The reasons for cancer to become a
preferred area of application for gene therapy
are the significant unmet medical needs in cancer
therapy, coupled with the large size of its
market. Additionally, the ethical acceptance of
gene therapy as a therapeutic solution also
contributed to the shift of focus from
monogenetic diseases to cancer. A major part of
the cancer gene therapy products for are
currently in preclinical and   Phase II of
clinical trials. There has been marginal success
in developing completely curative therapeutic
drugs. The gene therapy drugs which have been
approved till date are Gendicine Rexin-G.
Gendicine, which is developed by Shenzhen SiBiono
Gene Technologies Co., is currently marketed only
in China and Rexin-G in Philippines. Inquiry
Before Buying on this Report _at_ http//www.reportsn
reports.com/contacts/inquirybeforebuy.aspx?name27
6997 .
3
Cancer Gene Therapy Market Analysis

• Cancer Gene Therapy Report Highlights Findings
• Cancer Gene Therapy Drugs in Pipeline More Than
  60
• Highest Number of Drugs in Preclinical Stage 37
• Suspended Discontinued Cancer Gene Therapy Drug
  Pipeline 100
• Significance of Oncology Therapeutics in Gene
  Therapy
• Current Applications of Gene Therapy to Cancer
  Treatment
• Favorable Parameters for Cancer Gene Therapy
• Table of Contents
• 1. Introduction to Gene Therapy1.1 History of
  Gene Therapy1.2 Vectors of Gene Therapy
• 2. Global Gene Therapy Market2.1 Market
  Overview2.2 Emerging Trends in Gene Therapy
• 3. Significance of Cancer Therapeutics in Gene
  Therapy
• 4. Current Applications of Gene Therapy to Cancer
  Treatment4.1 Cancer Treatments Currently
  Available4.2 Approaches to Cancer Gene
  Therapy4.3 Gene Therapy Used in Cancer
  Treatment4.4 Methods of Inserting Genes into
  Cancer Patients

Browse more research reports on
Biotechnology_at_ http//www.reportsnreports.com/mark
et-research/biotechnology/ .
4
Cancer Gene Therapy Market Analysis
5. Cancer Gene Therapy Market Dynamics5.1
Favorable Parameters for Cancer Gene Therapy5.2
Issued Involved with Application of Gene Therapy
in Cancer Patients5.3 Cancer Gene Therapy
Clinical Insight 6. Regulatory Scenario for Gene
Therapy Market6.1 EU6.2 US Complete report is
available _at_ http//www.reportsnreports.com/reports
/276997-cancer-gene-therapy-market-analysis.html
. 7. Cancer Gene Therapy Drug Clinical Trial
Insight by Phase, Country Target
Indications7.1 Unknown Phase7.2 Research7.3
Preclinical7.4 Phase I/II7.5 Phase II7.6 Phase
III 8. Marketed Cancer Gene Therapy Drugs 9.
Suspended Discontinued Cancer Gene Therapy Drug
Pipeline9.1 No Development Reported9.2
Discontinued9.3 Suspended
Browse more research reports on
Biotechnology_at_ http//www.reportsnreports.com/mark
et-research/biotechnology/ .
5
Cancer Gene Therapy Market Analysis
List of Figures Figure 3-1 Gene Therapy by
IndicationFigure 5-1 Favorable Parameters for
Cancer Gene TherapyFigure 5-2 Cancer Gene
Therapy Drug Clinical Pipeline by Phase (),
2014Figure 5-3 Cancer Gene Therapy Drug
Clinical Pipeline by Phase (Number of Drugs),
2014Figure 5-4 Suspended Cancer Gene Therapy
Drug by Phase (), 2014Figure 5-5 Suspended
Cancer Gene Therapy Drug by Phase (Number of
Drugs), 2014Figure 5-6 Discontinued Cancer Gene
Therapy Drug by Phase (), 2014Figure 5-7
Discontinued Cancer Gene Therapy Drug by Phase
(Number of Drugs), 2014Figure 5-8 No
Development Reported Cancer Gene Therapy Drug by
Phase (), 2014Figure 5-9 No Development
Reported Cancer Gene Therapy Drug by Phase
(Number of Drugs), 2014 Buy a copy of report _at_
http//www.reportsnreports.com/purchase.aspx?name
276997 . Contact sales_at_reportsandreports.com /
Call 1 888 391 5441 for further information on
Cancer Gene Therapy Market Analysis report OR
for any other market research and intelligence
needs you may have for your business.
Browse more research reports on
Biotechnology_at_ http//www.reportsnreports.com/mark
et-research/biotechnology/ .
6
About ReportsnReports
ReportsnReports.com is your single source for all
market research needs. Our database includes
250,000 syndicated market research reports from
100 leading global publishers covering in-depth
analysis of over 5000 micro markets. With
comprehensive information about the publishers
and their report methodology, data sources, etc.
we help you in your purchase decision by mapping
your information needs with the most relevant
available reports in our library. Connect with
us sales_at_reportsandreports.com 1 888 391 5441
Contact sales_at_reportsandreports.com for further
information.
Contact sales_at_reportsandreports.com for further
information.